{
  "id": 4989,
  "url": "https://nnemf.org/research/4989-preliminary-study-of-pulsed-electromagnetic-fields-effects-on",
  "title": "Preliminary study of pulsed-electromagnetic fields effects on endothelial (HUVEC) cell secretions--modulation of the thrombo-hemorrhagic balance.",
  "authors": [
    "Adrien Caprani",
    "Alain Richert",
    "Jean-Paul Guglielmi",
    "Patrice Flaud"
  ],
  "journal": "Electromagnetic biology and medicine",
  "year": "2008",
  "doi": "10.1080/15368370802414145",
  "pmid": "19037787",
  "abstract": "We investigated the role of low-amplitude magnetic pulse with low repetition frequency superimposed on the environmental electromagnetic field (EMF) on the secretion of anti-aggregant (Prostacyclin or PGI(2)) and pro-aggregant (Thromboxane A(2)) agents in endothelial cells of the human umbilical cord vein (HUVEC). We established that magnetic pulse exposure modulates both PGI(2) and TXA(2). These modulations depend on the frequency, width of the pulse, and intensity of the magnetic field. Moreover, we corroborated previous results obtained with an endothelial cell line (EaHy-926), concerning the increased thrombo-embolic risk for the 1 Hz frequency.",
  "effect": "mixed",
  "evidence": "very_low",
  "extraction": {
    "studyType": "in_vitro",
    "studyTypeLabel": "In vitro study",
    "effectDirection": "mixed",
    "evidenceLabel": "Very low",
    "population": "Human umbilical cord vein endothelial cells (HUVEC)",
    "sampleSize": "—",
    "exposure": "pulsed magnetic field superimposed on environmental EMF",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "Low-amplitude magnetic pulse exposure with low repetition frequency modulated secretion of both PGI2 (anti-aggregant) and TXA2 (pro-aggregant) in HUVEC. The modulation depended on pulse frequency, pulse width, and magnetic field intensity, and the authors report increased thrombo-embolic risk at 1 Hz consistent with prior endothelial cell line findings.",
    "outcomes": [
      "Secretion/modulation of prostacyclin (PGI2)",
      "Secretion/modulation of thromboxane A2 (TXA2)",
      "Thrombo-hemorrhagic balance / thrombo-embolic risk (inferred from PGI2/TXA2 changes)"
    ],
    "limitations": [
      "In vitro cell model",
      "findings may not translate to humans",
      "Exposure parameters not fully specified in abstract (e.g.",
      "exact field strengths",
      "pulse widths",
      "exposure duration)",
      "Sample size and statistical details not reported in abstract"
    ],
    "keywords": [
      "pulsed electromagnetic fields",
      "magnetic pulse",
      "environmental EMF",
      "HUVEC",
      "endothelial cells",
      "prostacyclin",
      "PGI2",
      "thromboxane A2",
      "TXA2",
      "platelet aggregation",
      "thrombo-hemorrhagic balance",
      "thrombo-embolic risk",
      "1 Hz"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"in_vitro\",\n  \"exposure\": {\n    \"band\": null,\n    \"source\": \"pulsed magnetic field superimposed on environmental EMF\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Human umbilical cord vein endothelial cells (HUVEC)\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Secretion/modulation of prostacyclin (PGI2)\",\n    \"Secretion/modulation of thromboxane A2 (TXA2)\",\n    \"Thrombo-hemorrhagic balance / thrombo-embolic risk (inferred from PGI2/TXA2 changes)\"\n  ],\n  \"main_findings\": \"Low-amplitude magnetic pulse exposure with low repetition frequency modulated secretion of both PGI2 (anti-aggregant) and TXA2 (pro-aggregant) in HUVEC. The modulation depended on pulse frequency, pulse width, and magnetic field intensity, and the authors report increased thrombo-embolic risk at 1 Hz consistent with prior endothelial cell line findings.\",\n  \"effect_direction\": \"mixed\",\n  \"limitations\": [\n    \"In vitro cell model; findings may not translate to humans\",\n    \"Exposure parameters not fully specified in abstract (e.g., exact field strengths, pulse widths, exposure duration)\",\n    \"Sample size and statistical details not reported in abstract\"\n  ],\n  \"evidence_strength\": \"very_low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"pulsed electromagnetic fields\",\n    \"magnetic pulse\",\n    \"environmental EMF\",\n    \"HUVEC\",\n    \"endothelial cells\",\n    \"prostacyclin\",\n    \"PGI2\",\n    \"thromboxane A2\",\n    \"TXA2\",\n    \"platelet aggregation\",\n    \"thrombo-hemorrhagic balance\",\n    \"thrombo-embolic risk\",\n    \"1 Hz\"\n  ],\n  \"suggested_hubs\": [\n    {\n      \"slug\": \"elf-emf\",\n      \"weight\": 0.6,\n      \"reason\": \"Low repetition frequency (e.g., 1 Hz) pulsed magnetic field exposure.\"\n    },\n    {\n      \"slug\": \"mechanisms-in-vitro\",\n      \"weight\": 0.85,\n      \"reason\": \"In vitro endothelial cell secretion changes (PGI2/TXA2) under pulsed magnetic field exposure.\"\n    }\n  ]\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/19037787/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=4989",
  "updated": "2026-02-14 08:11:23"
}